Chandra Bhagat Pharma Limited is engaged in the marketing of lifesaving medicines in India such as Cardiovascular, Antineoplastic, Antibiotics and Hormone medicines.
| Bidding Dates |
|---|
| 31 Jan 2020 - 06 Feb 2020 |
| Subscription |
|---|
| 1.65x Oversubscribed |
| Minimum Investment | Minimum Lot | Maximum Lot | Lot Size | Number of Shares | Issue Price | Post Issue Promoter Holding % | Issue Size | IPO Document |
|---|---|---|---|---|---|---|---|---|
| ₹1,02,000 | 1 | 1 | 2000 | 2.0 M | ₹51 | 73.49 % | ₹102.0 M | RHP DOC |
Chandra Bhagat Pharma IPO SUBSCRIPTION STATUS
06 Feb '20Chandra Bhagat Pharma IPO overall subscription rate was 1.65 times the total available shares
Chandra Bhagat Pharma IPO retail subscription rate was 1.44 times in the retail segment
Chandra Bhagat Pharma IPO non-institutional investor subscription rate was 1.87 times in the non-institutional investor category
| Day | Retail Individual Investor | HNI (NII) Investors | Qualified Institutional Buyers |
|---|---|---|---|
| Category Reservation | 50% | 50% | - |
06 Feb 2020 (Day 5) | 1.44x | 1.87x | - |
31 Jan 2020 (Day 1) | 0.08x | 1.44x | - |
03 Feb 2020 (Day 2) | 0.25x | 1.52x | - |
04 Feb 2020 (Day 3) | 0.41x | 1.54x | - |
05 Feb 2020 (Day 4) | 0.55x | 1.58x | - |
Chandra Bhagat Pharma FINANCIALS
| Period | Net Profit (Rs in millions) | Revenue from operations (Rs in millions) | Cash Flow from operations (Rs in millions) | Free Cash flow (Rs in millions) |
| 4MFY20 | 2.5 | 333.5 | 34.1 | 34.1 |
| FY19 | 6.3 | 1,062.8 | 38.3 | 38.2 |
| FY18 | 10.3 | 970.6 | -61.8 | -61.9 |
| FY17 | 6.6 | 897.9 | -90.3 | -90.3 |
Chandra Bhagat Pharma IPO SUBSCRIPTION STATUS DETAILS
Chandra Bhagat Pharma had 2.0 M shares on offer
Chandra Bhagat Pharma IPO offer price was ₹51
Chandra Bhagat Pharma IPO minimum Investment was ₹102000
Chandra Bhagat Pharma IPO issue size was ₹ 102.0 M
Chandra Bhagat Pharma had a minimum lot size of 2000 Shares per application
Chandra Bhagat Pharma NUMBER OF SHARES ON OFFER
Chandra Bhagat Pharma IPO IMPORTANT DATES
| Issue Open Date | 31 Jan 2020 |
| Issue close Date | 06 Feb 2020 |
| Allotment Date | 11 Feb 2020 |
| Refund Date | 13 Feb 2020 |
| Demat Account Credit Date | 13 Feb 2020 |
| Listing Date | 14 Feb 2020 |
| Listing on Exchange(s) | BSE |
| Chandra Bhagat Pharma Allotment Status | Exchange |
Chandra Bhagat Pharma IPO subscription opened on 31 Jan 2020, and closed on 06 Feb 2020
IPO allotment for Chandra Bhagat Pharma was finalized on Tuesday, 11 Feb 2020
IPO listing for Chandra Bhagat Pharma was on BSE on Friday, 14 Feb 2020
Chandra Bhagat Pharma IPO LISTING GAINS
| Issue Price (adjusted) | 51.0 |
| Listing Open Price | 51.7 |
| Listing Close Price | 51.8 |
| Listing Gain% | 1.4% |
| Current Gain% | -14.9% |
Chandra Bhagat Pharma Peer
| Stock | Stock Price | Market Cap (Rs crore) | PE TTM | PEG TTM | PS TTM | ROE% | ROA% | Annual Revenue (Rs crore) | Annual Revenue Growth % | Annual Net Profit (Rs crore) | Annual Net Profit Growth % | EPS TTM | EPS TTM Growth % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chandra Bhagat Pharma Ltd. | 43.4 | 32.7 | 10.7 | 0 | 0.3 | 9.2 | 3.2 | 119.6 | 29.7 | 3 | 255.1 | 4 | 255.1 |
| Sun Pharmaceutical Industries Ltd. | 1945 | 466670.7 | 38.6 | 2.3 | 7.8 | 13.7 | 10.6 | 60433.8 | 10.8 | 11479.4 | 5 | 50.4 | 16.6 |
| Divi's Laboratories Ltd. | 8275 | 219675.3 | 75.1 | 2.8 | 19.6 | 15.3 | 12.8 | 11067 | 14 | 2568 | 17.2 | 110.2 | 26.8 |
| Torrent Pharmaceuticals Ltd. | 4924 | 187293.2 | 85.9 | 9.6 | 11.9 | 25.8 | 4.9 | 13886.2 | 20.3 | 2163.4 | 13.2 | 57.3 | 8.9 |
| Cipla Ltd. | 1463.8 | 118253.6 | 35.1 | -0.9 | 4.2 | 11.3 | 9.1 | 29044.6 | 2.2 | 3879.2 | -26.4 | 41.7 | -37.5 |
| Zydus Lifesciences Ltd. | 1114.2 | 112114.6 | 22.2 | 2.3 | 4.1 | 18.6 | 9.6 | 27657.9 | 17.6 | 5040 | 11.4 | 50.1 | 9.6 |
Chandra Bhagat Pharma INFORMATION ON IPO ISSUE
About Chandra Bhagat Pharma
Chandra Bhagat Pharma Limited is engaged in the marketing of lifesaving medicines in India such as Cardiovascular, Antineoplastic, Antibiotics and Hormone medicines.
Object of the Issue
- To Meet Incremental Working Capital Requirements
- Setting up Distribution and Warehousing Centres
- General Corporate Purpose;
- To meet Public Issue Expenses
Chandra Bhagat Pharma - PROMOTERS
| Name |
|---|
| Hemant Chandravadan Bhagat |
| Pranav Hemant Bhagat |
Chandra Bhagat Pharma Lead Manager to the Issue
Beeline Broking Limited
mb@beelinemb.com
Chandra Bhagat Pharma Registrar to the Offer
Link Intime India Private Limited
cbpl.ipo@linkintime.co.in
Chandra Bhagat Pharma Strengths
Experienced Promoters and management team
Promoters have played a key role in guiding, developing, and growing businesses. Under the leadership and experience of the Promoters, the company has seen significant growth in the overall business
Scalable Business Model
The company believes that it has a scalable business model as a business model is customer-centric and order driven, and requires optimum utilization of existing resources, assuring quality supply and achieving consequent economies of scale.
Chandra Bhagat Pharma Risks
Business largely depends on the performance of distributors
The business largely depends on the performance of distributors. Any nonperformance by these distributors may adversely affect business operations, profitability and cash flows.
Need to obtain and renew certain registrations, licenses and permits
Business requires to obtain and renew certain registrations, licenses, and permits from the government and regulatory authorities and the failure to obtain and renew them in a timely manner may adversely affect business operations.
IPO FAQs
The promoters of the company are Hemant Chandravadan Bhagat and Pranav Hemant Bhagat.
The category allocation of qualified institutional buyers is 0.0%, the category allocation of non individual investors or high networth individuals is 50.0% and for retail investors it is 50.0%.
The price band of the IPO is Rs 51.0 - 51.0.
The IPO application opens on Jan 31, 2020 and closes on Feb 06, 2020.
The minimum lot size for the IPO is 2000. The maximum lot size for the IPO is 2000.
For all category investors, the minimum application amount for this IPO is Rs. 102,000.0, the maximum value for this IPO is Rs 102,000.0.
This IPO will be allotted on Feb 11, 2020.
The refund will be credited to your account on Feb 13, 2020.
The allotted shares will be credited to your demat on Feb 13, 2020.
Chandra Bhagat Pharma Ltd.’s shares listed on the stock exchanges on Feb 14, 2020.